© 2021 BioMarin. All rights reserved.
| Recent Price | $79.40 |
|---|---|
| 52 Week High | $131.95 |
| 52 Week Low | $71.35 |
| Average Volume (30 days) | 1.10M |
| Beta | 0.59 |
| Market Cap | $14.50B |
|---|---|
| Shares Outstanding | 182.66M |
| Float | 141.50M |
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | -- |
| Quick Ratio (MRQ) | 3.1 |
|---|---|
| Current Ratio (MRQ) | 4.8 |
| LT Debt/Capital (MRQ) | 21% |
| Total Debt/Equity (MRQ) | 26% |
| Price/Earnings (TTM) | 17.80 |
|---|---|
| Price/Sales (TTM) | 10.68 |
| Price/Book (MRQ) | 3.50 |
| Price/Cash Flow (TTM) | 176.90 |
| Earnings (TTM) | $4.43 |
|---|---|
| Sales (TTM) | $7.44 |
| Book Value (MRQ) | $22.48 |
| Cash Flow (TTM) | $0.45 |
| Cash (MRQ) | $5.87 |
| Return on Equity (TTM) | 22.9% |
|---|---|
| Return on Assets (TTM) | 15.7% |
| Return on Investment (TTM) | 18.2% |
| Gross Margin (TTM) | 71.6% |
|---|---|
| EBIT Margin (TTM) | -0.7% |
| Profit Margin (TTM) | 59.0% |